Being interested in cancer therapies now is interesting. New prospects for therapeutic intervention that are actually "target oriented" have emerged as a result of a better understanding of the molecular components of cancer. These novel medicines provide the possibility of really selective cancer therapies that are tailored to the specific tumour of each patient, which is considerably different from the traditional chemotherapeutic medications. Cancer pharmacology is crucial to the development of new medications. Cancer pharmacology has had to adapt to the evolving nature of drug development in both the laboratory and the clinic by developing experimental models and target-oriented methodologies. The curriculum is meant to give you a "state-of-the-art" training in contemporary cancer pharmacology that satisfies employer demand and offers an expert